Quick Answer
BioAge Labs, Inc. reported Net Income of -$80.61 million for fiscal year 2025.
BioAge Labs, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$80.61M | -13.4% |
| 2024 | -$71.11M | -11.4% |
| 2023 | -$63.85M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$20.17M | +13.8% | +6.5% |
| June 30, 2025 | -$21.56M | -58.8% | -66.8% |
| March 31, 2025 | -$12.93M | +0.5% | +44.8% |
| September 30, 2024 | -$23.41M | -60.0% | -72.4% |
| June 30, 2024 | -$13.58M | +21.0% | -4.5% |
| March 31, 2024 | -$12.99M | -17.2% | +11.2% |
| September 30, 2023 | -$14.62M | — | +14.9% |
| June 30, 2023 | -$17.19M | — | -55.1% |
- BioAge Labs, Inc. showed a decrease of -13.4% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, BioAge Labs, Inc.’s net income has declined by 26.2% (from -$63.85 million to -$80.61 million).
- The most recent figure is from BioAge Labs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: